<DOC>
	<DOC>NCT02922426</DOC>
	<brief_summary>This study will characterize insulin sensitivity in response to treatment with ALKS 3831, olanzapine, and placebo.</brief_summary>
	<brief_title>An Insulin Sensitivity Study in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Body Mass Index (BMI) between 18.0 and &lt; 25.0 kg/m^2 at screening and randomization No prior history of regular smoking or nicotine use Women of childbearing potential should be on stable regimens of oral contraceptives for at least 2 months prior to screening Subjects must be willing to avoid a regular exercise regimen from screening through the end of the treatment period Additional criteria may apply Has current evidence or history of any clinically significant medical or psychiatric condition or observed abnormality Is currently pregnant or breastfeeding, or is planning to become pregnant during the study Has a lifetime history of diabetes Has a known risk of narrowangle glaucoma Has a clinically significant illness within 30 days prior to screening or admission to the clinic Has a history of dependence on any substance other than caffeine Has a current or anticipated need for prescribed opioid medication (eg, planned surgery) during the study period Has a positive urine drug screen for drugs of abuse at screening or admission to the study site Has had a serious infection (eg, pneumonia or septicemia) within the 3 months prior to screening or admission to the clinic Has had any vaccinations in the 4 weeks prior to screening or admission to the clinic Chronic use of nonsteroid antiinflammatory drugs (NSAIDs) and acetaminophen, except for lowdose Aspirin is not allowed Use of new prescription and nonprescription drugs, as well as dietary/nutritional supplements within 3 weeks preceding the first dosing of study drugs, unless approved by Investigator Has prior use of any antipsychotic medication, including on and off label uses Additional criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>ALKS 3831</keyword>
	<keyword>Samidorphan</keyword>
	<keyword>Olanzapine</keyword>
</DOC>